Table 2

Estimated parameters from growth curve analysis of continuous outcomes

Effect sizes (Cohen's d) with 95% CIRate of change
MeasurePre
M (SD)
Post
M (SD)
6 MFU
M (SD)
LFU
M (SD)
Pre to postPre to 6 MFUPre to LFUPre to Post
β
95% CI
Post to LFU
β
95% CI
LSAS-SR69.07 (22.90)50.38 (24.37)46.13 (26.21)41.87 (24.24)0.79 [0.69 to 0.89]0.92 [0.75 to 1.09]1.17 [1.02 to 1.32]−18.69*** [−20.63 to −16.74]−4.26*** [−5.33 to −3.09]
MADRS-S14.57 (7.62)9.78 (8.03)9.63 (9.11)9.48 (7.97)0.61 [0.52 to 0.70]0.59 [0.42 to 0.75]0.67 [0.54 to 0.80]−4.78*** [−5.45 to −4.12]−0.15 [−0.59 to −0.28]
EQ-5D0.81 (0.13)0.82 (0.15)0.83 (0.18)0.85 (0.18)−0.12 [−0.22 to 0.01]−0.17 [−0.36 to 0.02]−0.25 [−0.40 to −0.10]0.02* [0.00 to 0.03]0.01* [0.00 to 0.02]
  • Observed means and SDs for pretreatment, and estimated means and observed SDs for post-treatment, 6-month follow-up and long-term follow-up are reported. For Cohen’s d, an effect size of 0.2 is considered to be a small effect, 0.5 a medium effect and >0.8 a large effect. For slope coefficients of rate of change, significant effects of time on outcome are denoted as ***p<0.001; **p<0.01 and *p<0.05.

  • 6 MFU, 6 months after treatment; EQ-5D, health-related quality of life; LFU, long-term follow-up 1.2–4 years after treatment start; LSAS-SR, Liebowitz Social Anxiety Scale questionnaire Self-Report; M, mean; MADRS-S, Montgomery Åsberg Depression Rating Scale Self-report; Post, post-treatment; Pre, before treatment.